Riga First Hospital invites patients with psoriasis to participate in a study aimed at tracking the progression of the disease and the effectiveness of treatment.
This offer is intended for patients with psoriasis who want not only to start treatment with experienced specialists but also to participate in a scientific study.
The hospital notes that study participants will receive regular monitoring and assessment of treatment dynamics from Professors Ingmars Mikājans and Ilona Harmane.
Participants will be provided with the opportunity to use a digital health model that will help track the course of the disease and the results of therapy. They will also receive medical assistance within the framework of state services.
To participate in the study, patients need to register through the electronic booking system of the Riga First Hospital or contact the registration and information center by phone at 67366323.
